ADN 138

Overview

ADN-138 is an aldose reductase inhibitor. ADN-138 reduces sorbitol levels in diabetic nerves and results in significant increases in MNCV and Na + , K + -ATPase in the nerves. ADN-138 can be used in the research of diabetic nerve complications.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Na+/K+ ATPase | Products > Signaling Pathways > Aldose Reductase | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-113738
• CAS No.: 99434-90-9
• Molecular Formula: C13H9ClN2O4
• Molecular Weight: 292.67
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source